0001209191-20-025816.txt : 20200427 0001209191-20-025816.hdr.sgml : 20200427 20200427164816 ACCESSION NUMBER: 0001209191-20-025816 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190628 FILED AS OF DATE: 20200427 DATE AS OF CHANGE: 20200427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee Kevin CENTRAL INDEX KEY: 0001776938 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38916 FILM NUMBER: 20820779 MAIL ADDRESS: STREET 1: C/O BICYCLE THERAPEUTICS LIMITED STREET 2: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB223AT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc CENTRAL INDEX KEY: 0001761612 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT BUSINESS PHONE: 011441223261503 MAIL ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT FORMER COMPANY: FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd DATE OF NAME CHANGE: 20181212 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2019-06-28 2019-05-30 0 0001761612 BICYCLE THERAPEUTICS plc BCYC 0001776938 Lee Kevin C/O BICYCLE THERAPEUTICS PLC B900, BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT UNITED KINGDOM 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 14.00 2019-06-28 4 A 0 506252 0.00 A 2029-06-28 Ordinary Shares 506252 506252 D The original Form 4 inadvertently listed the incorrect date of earliest transaction, transaction date and expiration date. This Form 4 amendment is being filed to accurately reflect the appropriates dates. This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. /s/ Lee Kalowski, as Attorney-in-Fact 2020-04-27